Wed, 4 Nov
Global Health
Global Health delivered strong results driven by high-occupancy and scale-up at Noida. Expansion remains aggressive with a new 500-bed Ghaziabad project.
Summary ready
Earnings calls
Global Health concalls
Every Global Health earnings call we streamed: the live audio and our summary of what management said.
Calls
Q2 FY27: key takeaways
Call page →Global Health delivered strong results driven by high-occupancy and scale-up at Noida. Expansion remains aggressive with a new 500-bed Ghaziabad project.
Outlook
Planned capex of ₹6,000 Cr to double bed capacity over 4-5 years.
Earlier call summaries
All →
16:16 IST
NSE
Earnings Call
Global Health Earnings Call Transcript: Key Takeaways
Global Health (Medanta) delivered strong 26% revenue growth, fueled by higher patient volumes and a rapid turnaround in the new Noida facility.
10:09 IST
BSE
Earnings Call
Global Health Earnings Call: Key Takeaways
Global Health Limited reported FY26 total income growth of 20% to ₹45,089 million with consolidated PAT up 15.1% to ₹5,541 million. Growth was driven by patient volume increases and scaling of developing hospitals.
16:08 IST
BSE
Earnings Call
Global Health Earnings Call: Key Takeaways
Medanta delivered a robust FY26 with 20% revenue growth, driven by rapid ramp-up in Noida and maturity in Lucknow/Patna. Management is balancing high-intensity expansion with maintained 24-25% EBITDA margins.
18:47 IST
NSE
Earnings Call
Global Health Earnings Call: Key Takeaways
Global Health (Medanta) reported strong FY26 performance with 20% revenue growth and 15% PAT growth. Expansion continues with Noida facility now operational and new projects in Varanasi and Indore.
Global Health Limited: key numbers
- Share price
- ₹1,410.00
- Market cap
- ₹37,912 Cr
- Revenue (annual)
- ₹4,410 Cr
- Net profit (annual)
- ₹556.5 Cr
- P/E (TTM)
- 61.3×Sector 53.8×
- Promoter holding
- 33.00%+0.00% QoQ
- FII holding
- 9.92%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.